Back to overview

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

4317studies shown

Showing 373-384 of 4,317

Other study type icon

RecruitingACTRN12624001116516

Addressing health equity by screening for neurodevelopmental concerns in primary healthcare

Official study title

Evaluating the effect of the Tracking Cube on identification of neurodevelopmental concerns in primary healthcare

In Australia

ADHDInterventional studyAges 0 months+

Countries: Australia
Sponsor: Griffith University

Other study type icon

RecruitingNCT07114471

A mobile health tool for worries in early pregnancy

About this title

Addressing Pregnant Women's First Trimester Worries and Information Needs With mHealth Solutions

Read the official source — NCT07114471

Official study title

Exploring the Anxieties and Health Information Needs of Women in the First Trimester to Inform mHealth Solutions for Antenatal Care

In London

AnxietyObservational studyAges 18+

Countries: United Kingdom
Sponsor: Bournemouth University

Behavioral study icon

RecruitingNCT06573476

Peer recovery coaching and text support after opioid-related harms

About this title

Addressing Racial Disparities in Opioid Overdose Using Peer Recovery Coach Training and mHealth Platform

Read the official source — NCT06573476

Official study title

Addressing Racial Disparities in Opioid Overdose Deaths Using an Open Source Peer Recovery Coach Training and Multimodal Mobile Health Platform

In New York

AddictionBehavioural studyAges 18–99

Countries: United States
Sponsor: Friends Research Institute, Inc.

Device study icon

RecruitingNCT06325813

Active or sham brain stimulation for inhibitory control in children with ADHD

About this title

ADHD PreSMA Response Inhibition Therapy

Read the official source — NCT06325813

Official study title

ADHD PreSMA Response Inhibition Therapy

In Cincinnati

ADHDDevice studyAges 12–17

Countries: United States
Sponsor: Children's Hospital Medical Center, Cincinnati

Other study type icon

RecruitingNCT07228650

ADHD Remote Technology and ADHD Transition: Predicting and Preventing Negative Outcomes

In London

ADHDObservational studyAges 16–17

Countries: United Kingdom
Sponsor: King's College London (University)

Behavioral study icon

RecruitingNCT07504107

ADHD&me: Targeting Self-esteem in Youth With ADHD

Official study title

ADHD&me: a Randomized Controlled Trial to Target Self-esteem in Youth With ADHD

In Haarlem

ADHDBehavioural studyAges 16–25

Countries: Netherlands
Sponsor: Universiteit Leiden

Biological study icon

RecruitingNCT03522545

Testing stem cells added to usual care for depression in bipolarity

About this title

Adjunctive Allogeneic Mesenchymal Stem Cells for Treatment-resistant Bipolar Depression

Read the official source — NCT03522545

Official study title

Adjunctive Allogeneic Mesenchymal Stem Cells for Treatment-resistant Bipolar Depression

In Houston

Depression, BipolarityPlacebo comparisonAges 18–65

Countries: United States
Sponsor: The University of Texas Health Science Center, Houston

Device study icon

RecruitingNCT06973759

Bright light therapy for adolescents with depression and eveningness

About this title

Adjunctive Bright Light Therapy in Adolescents With Depression and Eveningness

Read the official source — NCT06973759

Official study title

Bright Light Therapy for Adolescents With Depression and Eveningness - a Randomized, Placebo-controlled, Assessor-blinded Study

In Hong Kong

DepressionDevice studyAges 12–19

Countries: China
Sponsor: Chinese University of Hong Kong

Drug study icon

RecruitingNCT06940674

Cannabidiol added to care for opioid use disorder

About this title

Adjunctive Cannabidiol for Recovery From Opioid Study

Read the official source — NCT06940674

Official study title

Adjunctive Cannabidiol for Recovery From Opioid Study (ACROS)

Multiple locations, including New York

AddictionMedication studyAges 18–65

Countries: United States
Sponsor: Icahn School of Medicine at Mount Sinai

Drug study icon

RecruitingNCT04161066

Safety study of psilocybin with buprenorphine for opioid use disorder

About this title

Adjunctive Effects of Psilocybin and a Formulation of Buprenorphine

Read the official source — NCT04161066

Official study title

Phase I Study of the Safety and Adjunctive Effects of Psilocybin in Adults With Opioid Use Disorder Maintained on a Buprenorphine/Naloxone Formulation

In Madison

AddictionMedication studyAges 21–65

Countries: United States
Sponsor: University of Wisconsin, Madison

Drug study icon

RecruitingNCT06218030

L-methylfolate added to usual care for treatment-resistant generalized anxiety

About this title

Adjunctive Treatment With L-methylfolate for Treatment-Resistant Generalized Anxiety Disorder: a Pilot Study

Read the official source — NCT06218030

Official study title

PSIY-744-23: Adjunctive Treatment With L-methylfolate for Treatment-Resistant Generalized Anxiety Disorder: a Pilot Study

In Kingston

AnxietyMedication studyAges 18–65

Countries: Canada
Sponsor: Queen's University

Device study icon

RecruitingNCT06885554

Adjustment symptoms and recovery in US military personnel

About this title

Adjustment Disorders in the US Military: Disease Trajectories and ADNM-20-Mil Validation

Read the official source — NCT06885554

Official study title

Adjustment Disorders in the US Military: Disease Trajectories and ADNM-20-Mil Validation

Multiple locations, including San Diego

Adjustment disorderDevice studyAges 18–64

Countries: United States
Sponsor: Henry M. Jackson Foundation for the Advancement of Military Medicine

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.